Silvio E. Inzucchi
0000-0003-1254-6636
Publication & Citation Trends
Publications
0 total
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.
Cited by 0
Semantic Scholar
Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial
Cited by 0
Semantic Scholar
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial OA
Cited by 9
Semantic Scholar
Abstract WP229: Comparing the Real-World Effects of Once-Weekly Semaglutide and Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcomes, Health Care Resource Utilization, and Medical Costs in Individuals With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Cited by 0
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(469)
Diabetes Management and Research
(220)
Metabolism, Diabetes, and Cancer
(174)
Pancreatic function and diabetes
(168)
Cardiovascular Function and Risk Factors
(117)
Affiliations
University of Vermont
University of North Carolina at Chapel Hill
Texas Tech University
Western University
University of Maryland, Baltimore